Open Access. Powered by Scholars. Published by Universities.®

Chemistry Commons

Open Access. Powered by Scholars. Published by Universities.®

PDF

Cleveland State University

Series

Breast cancer; Aromatase inhibitor; Resistance; COX-2 inhibitor; Nimesulide

Publication Year

Articles 1 - 2 of 2

Full-Text Articles in Chemistry

In Vitro And In Vivo Effects Of A Cyclooxygenase-2 Inhibitor Nimesulide Analog Jcc76 In Aromatase Inhibitors-Insensitive Breast Cancer Cells, Bo Zhong, Xiaohan Cai, Xing Yi, Aimin Zhou, Shiuan Chen, Bin Su Aug 2011

In Vitro And In Vivo Effects Of A Cyclooxygenase-2 Inhibitor Nimesulide Analog Jcc76 In Aromatase Inhibitors-Insensitive Breast Cancer Cells, Bo Zhong, Xiaohan Cai, Xing Yi, Aimin Zhou, Shiuan Chen, Bin Su

Chemistry Faculty Publications

Third generation aromatase inhibitors (AIs) are more effective than tamoxifen in the treatment of estrogen receptor (ER) positive breast cancer. However, long-term use of AIs commonly results in resistance. We examined whether compound JCC76{Cyclohexanecarboxylic acid [3-(2,5-dimethyl-benzyloxy)-4-(methanesulfonyl-methyl-amino)-phenyl]-amide}, an analog of Cyclooxygenase-2 (COX-2) inhibitor nimesulide, can inhibit the growth of AI-insensitive breast cancer cells and the mechanisms by which the compound affects cell proliferation. LTEDaro (long term estrogen deprived MCF-7aro cell) cells, which are a model for AI resistance, were used in this study. JCC76 effectively inhibited LTEDaro cell proliferation with an IC50 of 2.75 ± 0.31 μM. Further investigations reveal that …


Lead Optimization Of Cox-2 Inhibitor Nimesulide Analogs To Overcome Aromatase Inhibitor Resistance In Breast Cancer Cells, Bin Su, Shiuan Chen Dec 2009

Lead Optimization Of Cox-2 Inhibitor Nimesulide Analogs To Overcome Aromatase Inhibitor Resistance In Breast Cancer Cells, Bin Su, Shiuan Chen

Chemistry Faculty Publications

A series of COX-2 selective inhibitor nimesulide derivatives were synthesized. Their anti-cell proliferation activities were evaluated with a long-term estrogen deprived MCF-7aro (LTEDaro) breast cancer cell line, which is the biological model of aromatase inhibitor resistance for hormone-dependent breast cancer. Compared to nimesulide which inhibited LTEDaro cell proliferation with an IC50 at 170.30 μM, several new compounds showed IC50 close to 1.0 μM.